SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-022260
Filing Date
2020-11-02
Accepted
2020-11-02 16:15:32
Documents
15
Period of Report
2020-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vcyt20200805_8k.htm   iXBRL 8-K 28227
2 EXHIBIT 99.1 ex_197472.htm EX-99.1 220678
7 prlogo.jpg GRAPHIC 6236
  Complete submission text file 0001437749-20-022260.txt   407864

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcyt-20201102.xsd EX-101.SCH 3701
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcyt-20201102_def.xml EX-101.DEF 11587
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcyt-20201102_lab.xml EX-101.LAB 15467
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcyt-20201102_pre.xml EX-101.PRE 11741
8 EXTRACTED XBRL INSTANCE DOCUMENT vcyt20200805_8k_htm.xml XML 2570
Mailing Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Filer) CIK: 0001384101 (see all company filings)

IRS No.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36156 | Film No.: 201280632
SIC: 8071 Services-Medical Laboratories